Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Acute Leukemia — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Leukemia
Acute Leukemia

Hematologic Malignancy

Acute Leukemia

CI-CAN-00000399Explore in graph →

Hematologic1,259 active trials30 approved drugs323 evidence items

NCIt: C9300
DOID: 12603

Overview
Statistics
Survival
Genomics17
Variants & evidence323
Drugs53
Trials4653
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

4,653 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,259
Recruiting: 759
Ph III recruiting: 70
Growth YoY: 0%
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (718)

StatusAll Active (any)Completed 1,768 Recruiting 880 Unknown 650 Terminated 546 Active Not Recruiting 327 Not Yet Recruiting 218 Withdrawn 176 Suspended 32 Enrolling By Invitation 30 No Longer Available 14 Available 7 Approved For Marketing 5

PhaseAll Early Phase 1 100 N/A 516 Phase 1 1,696 Phase 2 1,844 Phase 3 390 Phase 4 88

No study matches these filters